source
- Eli Lilly partners with China’s InnoCare on drug development deal worth up to $3.35 billionEli Lilly has signed a partnership agreement with Beijing-based InnoCare to co-develop new medicines. InnoCare will apply its internal drug discovery platform while Lilly will contribute its devel…
- Roche signs $2 billion deal with Atavistik to discover allosteric cardiovascular-renal-metabolic drugsRoche announced a partnership with Cambridge-based biotech Atavistik Bio to develop allosteric small-molecule therapies for cardiovascular, renal and metabolic diseases. The agreement includes an u…